| scholarly article | Q13442814 |
| P50 | author | Dario C Altieri | Q98158352 |
| P2093 | author name string | Robert M Weiss | |
| Xue-Ru Wu | |||
| David S Garlick | |||
| Dan Eisenberg | |||
| Tung-Tien Sun | |||
| Janet Plescia | |||
| Whitney Salz | |||
| P2860 | cites work | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3531-3534 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | A survivin gene signature predicts aggressive tumor behavior | |
| P478 | volume | 65 |
| Q38734925 | Activation of CXCL12/CXCR4 renders colorectal cancer cells less sensitive to radiotherapy via up-regulating the expression of survivin |
| Q80118132 | Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder |
| Q37987066 | Biomolecular predictors of urothelial cancer behavior and treatment outcomes |
| Q38170812 | Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder |
| Q39762427 | Chemically induced bladder cancer--a sonographic and morphologic description |
| Q47140262 | Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells |
| Q44962896 | Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). |
| Q36995765 | Clinical states model for biomarkers in bladder cancer |
| Q34221639 | Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter |
| Q41992293 | Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma |
| Q40040264 | Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells |
| Q46156165 | Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study |
| Q37279004 | Gene signatures for risk-adapted treatment of bladder cancer |
| Q58089982 | Glycoprotein-130 expression is associated with aggressive bladder cancer and is a potential therapeutic target |
| Q33638504 | IAP regulation of metastasis |
| Q34573226 | Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands |
| Q37902697 | Immunohistochemical biomarkers for bladder cancer prognosis |
| Q35048722 | Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines |
| Q36538470 | Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice |
| Q35374920 | Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer |
| Q43704191 | Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis |
| Q48034682 | Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma |
| Q34994521 | RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer |
| Q34225286 | Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma |
| Q55480165 | Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance. |
| Q36960662 | Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival |
| Q34078474 | Survival responses of human embryonic stem cells to DNA damage |
| Q26825700 | Survivin - The inconvenient IAP |
| Q39661250 | Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation |
| Q38433829 | Survivin expression is associated with bladder cancer presence, stage, progression, and mortality |
| Q37876468 | Survivin in skin pathologies |
| Q41528918 | Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study |
| Q34644740 | Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1 |
| Q34495409 | Survivin selectively modulates genes deregulated in human leukemia stem cells. |
| Q48345159 | Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker |
| Q26823439 | Survivin: A molecular biomarker in cancer |
| Q92918274 | The Application of Biomaterials in the Treatment of Platinum-Resistant Ovarian Cancer |
| Q33799676 | Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression |
| Q36131259 | Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response |
| Q38311193 | p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma |
Search more.